Table 1.
Clinical and demographical characteristics.
| Parameter | Group 1 | Group 2 | p |
|---|---|---|---|
| n = 90 | n = 58 | ||
| Sex (male (%)/female (%)) | 66 (73)/24 (27) | 36 (62)/22 (38) | 0.657 |
| Age (years) (median (Q1–Q3)) | 68 (57–73) | 72 (65–77) | 0.074 |
| Weight (kg) (median (Q1–Q3)) | 93 (92–94) | 90 (67–94) | 0.434 |
| Height (cm) (median (Q1–Q3)) | 168 (162–175) | 171 (161–176) | 0.703 |
| Body mass index (median (Q1–Q3)) | 29.7 (27.2–33.8) | 29.1 (25.7–31.5) | 0.398 |
| Co-morbidities: | |||
| Arterial hypertension (n(%)) | 47 (52) | 34 (59) | 0.445 |
| Diabetes mellitus (n(%)) | 26 (29) | 14 (24) | 0.525 |
| Hypercholesterolemia (n(%)) | 48 (53) | 30 (52) | 0.848 |
| COPD (n(%)) | 5 (6) | 3 (5) | 0.919 |
| Thyroid disease (n(%)) | 10 (11) | 5 (9) | 0.624 |
| Atrial fibrillation (n(%)) | 8 (9) | 4 (7) | 0.665 |
| Current nicotinism (n(%)) | 3 (3) | 1 (2) | 0.556 |
| Stroke (n(%)) | 3 (3) | 3 (5) | 0.58 |
| PAD (n(%)) | 9 (10) | 5 (9) | 0.78 |
| Current nicotinism (n(%)) | 3 (3) | 1 (2) | 0.556 |
| Echocardiographic results | |||
| Left ventricular diameter (mm) (median (Q1–Q3)) | 40 (38–43) | 47 (44–50) | 0.044 * |
| Left atrium diameter (mm) (median (Q1–Q3)) | 35 (30–37) | 39 (37–42) | 0.137 |
| Left ventricular ejection fraction (%)(median (Q1–Q3)) | 65 (60–65) | 55 (55–60) | 0.199 |
| Laboratory results | |||
| WBC (×109/L) (median (Q1–Q3)) | 7.48 (7.29–8.41) | 7.44 (6.13–8.67) | 0.669 |
| Neutrophils (×109/L) (median (Q1–Q3)) | 5.28 (4.90–5.64) | 4.14 (3.54–5.58) | 0.269 |
| Lymphocyte (×109/L) (median (Q1–Q3)) | 1.70 (1.54–2.11) | 1.98 (1.45–2.20) | 0.88 |
| Monocyte (×109/L) (median (Q1–Q3)) | 0.50 (0.42–0.52) | 0.46 (0.41–0.57) | 0.801 |
| Platelets (×109/L) (median (Q1–Q3)) | 218 (216–231) | 218 (178–255) | 0.88 |
| Hemoglobin (mmol/L) (median (Q1–Q3)) | 7.70 (7.55–8.30) | 8.60 (8.25–8.98) | 0.19 |
| Hematocrit (%) (median (Q1–Q3)) | 36 (35–40) | 38 (34–43) | 0.21 |
| MPV (fl) (median (Q1–Q3)) | 9.1 (8.5–9.4) | 8.4 (7.9–9.2) | 0.58 |
| MCV (median (Q1–Q3)) | 90 (89–92) | 93 (90–97) | 0.313 |
| MCHC (mmol/L) (median (Q1–Q3)) | 20.87 (20.82–20.97) | 20.96 (20.59–21.40) | 0.802 |
| RDW (%) (median (Q1–Q3)) | 12.60 (12.55–12.90) | 13.80 (13.18–14.18) | 0.030 * |
| Creatinine (median (Q1–Q3)) | 90 (83–108) | 92 (71–108) | 0.725 |
| GFR (umol/l) (median (Q1–Q3)) | 59 (57–65) | 74 (60–86) | 0.242 |
| Ureic acid (median (Q1–Q3)) | 296 (272–352) | 363 (317–403) | 0.634 |
Abbreviations: COPD, chronic obstructive pulmonary disease; GFR, glomerular filtration rate; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MPV, mean platelets volume; PAD, peripheral artery disease; RDW, red cells distribution width; * statistically significant.